Stock Market Stories and Insights

DXR
  over two weeks ago at Macroaxis 
By Achuva Shats
Daxor Corp is generating 0.427% of daily returns assuming volatility of 5.9174% on return distribution over 60 days investment horizon. While some of us are excited about healthcare space, it makes sense to sum up Daxor Corp in greater detail to make a better estimate of its risk and reward. We will cover the possibilities of Daxor Corp's current volatility to continue through July. Daxor Corp high volatility, while potentially profitable, can lead to more considerable losses for your portfolios.
AMSC
  over two weeks ago at Macroaxis 
By Achuva Shats
In general, we focus on analyzing Amer Superconductor (NASDAQ:AMSC) price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Amer Superconductor daily price indicators and compare them against related drivers. In this post we will go over Amer Superconductor. We will look into a few reasons why it is still possible for the company to generate above-average margins and positive cash flow.
SENS
  over two weeks ago at Macroaxis 
By Vlad Skutelnik
While many traders are getting carried away by overanalyzing healthcare space, it is reasonable to sum up Senseonics Holdings. We will analyze why Senseonics Holdings investors may still consider a stake in the business. Is the firm valuation justified? Here I will cover 2021 perspective on the current valuation of Senseonics Holdings to give you a better outlook on taking a possible position in this stock.
WINT
  over two weeks ago at Macroaxis 
By Achuva Shats
Lets try to review the odds of Windtree Therapeutics to fully recover from the newest drop as its shares went up 36.36%. Windtree Therapeutics current daily volatility is 7.78 percent, with a beta of 1.3 and an alpha of -1.32 over DOW. While some baby boomers are getting worried about overall trading value increase, it is reasonable to review Windtree Therapeutics. We will evaluate if Windtree Therapeutics shares are reasonably priced going into July.
MOSY
  over two weeks ago at Macroaxis 
By Raphi Shpitalnik
It looks like Diodes will continue to recover much faster as its share price surged up 3.42% today to MoSys's 20.0264%. As many rational traders are trying to avoid technology space, it makes sense to break down MoSys Inc a little further and understand how it stands against Diodes and other similar entities. We are going to inspect some of the competitive aspects of both MoSys and Diodes.
LPTH
  over two weeks ago at Macroaxis 
By Ellen Johnson
The next fiscal quarter end is expected on the 30th of June 2021. The stock goes through an active upward rally. Because some millenniums are getting more into technology space, we are going to concentrate on the feasibility of inclusion Lightpath into your portfolio. We will examine the reasons why it is still possible for the company to generate above-average margins given the current economic outlook.
GLMD
  over two weeks ago at Macroaxis 
By Achuva Shats
44% of stocks are less volatile than Galmed, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. As many investors are getting excited about healthcare space, it is fair to digest Galmed Pharmaceutica. What exactly are Galmed Pharmaceutica shareholders getting in July? Galmed Pharmaceutica high volatility, while potentially profitable, can lead to more considerable losses for your portfolios.
RESN
  over two weeks ago at Macroaxis 
By Raphi Shpitalnik
The stock is still going through an active upward rally. While some institutional investors are becoming indifferent towards technology space, we are going to outline the feasibility of picking up Resonant as a potential hedging instrument for your current portfolios. What exactly are Resonant shareholders getting in July?
FTEK
  over two weeks ago at Macroaxis 
By Raphi Shpitalnik
56% of stocks are less volatile than Fuel Tech, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. While many risk-averse traders are getting carried away by overanalyzing industrials space, it is reasonable to examine Fuel Tech. We will evaluate if the latest Fuel Tech price volatility suggests a bounce in July.
DXR
  over two weeks ago at Macroaxis 
By Ellen Johnson
Daxor Corp Current Ratio is relatively stable at the moment as compared to the past year. Daxor Corp reported last year Current Ratio of 1.49. As of 06/04/2021, Dividend Yield is likely to grow to 0.0249, while Earnings before Tax are likely to drop (11.4 M). The stock is currently experiencing an active upward rally. While some of us are getting worried about healthcare space, it is reasonable to sum up Daxor Corp using its current fundamental data. I will address the reasons this entity was abused by retail investors resulted from the current market uncertainty. Will retail investors continue to hold, or should we expect a sell-off?